Seborrheic Infantile Dermatitis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: SBR001 MIFTS: 34	Seborrheic Infantile Dermatitis Categories: Immune diseases, Skin diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Seborrheic Infantile Dermatitis

MalaCards integrated aliases for Seborrheic Infantile Dermatitis:

Name: Seborrheic Infantile Dermatitis ¹¹ ¹⁴ ¹⁶

Cradle Cap ¹¹ ⁷¹ ⁷⁵ ³³

Infantile Seborrhoeic Dermatitis ¹¹ ³³

Seborrhoeic Eczema of Scalp ¹¹ ³³

Seborrhoea Capitis ¹¹ ³¹

Infantile Seborrhoeic Dermatitis of the Scalp ³³

Generalized Seborrheic Dermatitis of Infants ¹¹

Complement Component 5 Deficiency ⁷¹

Seborrheic Dermatitis of Infancy ³³

Infantile Seborrheic Dermatitis ¹¹

Seborrhoeic Dermatitis of Scalp ¹¹

Neonatal Seborrhoeic Dermatitis ³³

Seborrheic Dermatitis of Scalp ⁷¹

Infantile Seborrhoeic Eczema ³³

Complement 5 Dysfunction ¹¹

Seborrheic Dermatitis ⁷¹

Scurfiness of Scalp ⁷¹

Pityriasis Capitis ¹¹

Seborrhea Capitis ¹¹

Seborrhea Sicca ¹¹

Dandruff ⁴³

Classifications:

MalaCards categories:
Anatomical: Skin diseases Immune diseases

See all MalaCards categories (disease lists)

ICD10: ³¹

Diseases of the skin and subcutaneous tissue

Dermatitis and eczema

Seborrhoeic dermatitis

Seborrhoea capitis

Seborrhoeic infantile dermatitis

ICD11: ³³

Diseases of the skin

Inflammatory dermatoses

Dermatitis and eczema

Seborrhoeic dermatitis and related conditions

Seborrhoeic dermatitis of the scalp

Skin disorders associated with pregnancy, the neonatal period and infancy

Dermatoses of infancy

Infantile seborrhoeic dermatitis

Cradle cap

External Ids:

Disease Ontology ¹¹ DOID:8941

ICD9CM ³⁴ 690.11

MeSH ⁴³ D063807

SNOMED-CT ⁶⁸ 48596006

ICD10 ³¹ L21.0 L21.1

EFO ¹⁶ EFO_1000765

ICD11 ³³ 1010943819 1315633810 1493830367

UMLS ⁷¹ C0036508 C0221244 C0263233 more

Sources

Summaries for Seborrheic Infantile Dermatitis

Disease Ontology: ¹¹ A seborrheic dermatitis that involves fungal infection of the scalp of recently born babies caused by Malassezia furfur. It is occasionally linked to immune disorders. The symptoms include thick, crusty, yellow or brown scales over the child's scalp.

MalaCards based summary: Seborrheic Infantile Dermatitis, also known as cradle cap, is related to seborrheic dermatitis and dermatitis. An important gene associated with Seborrheic Infantile Dermatitis is DOP1B (DOP1 Leucine Zipper Like Protein B). The drugs Ciclopirox and Ketoconazole have been mentioned in the context of this disorder. Affiliated tissues include skin and liver.

Wikipedia: ⁷⁵ Cradle cap or cradle hat causes crusty or oily scaly patches on a baby's scalp. The condition is not... more...

Sources

Related Diseases for Seborrheic Infantile Dermatitis

Diseases in the Seborrheic Dermatitis family:

Seborrheic Infantile Dermatitis

Diseases related to Seborrheic Infantile Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 50)

#	Related Disease	Score	Top Affiliating Genes
1	seborrheic dermatitis	31.1	ZNF750 MPZL3 FLG
2	dermatitis	10.4
3	anterior cutaneous nerve entrapment syndrome	10.2
4	skin disease	10.2
5	ichthyosis with confetti	10.2
6	alopecia	10.1
7	pyoderma	10.1
8	acne	10.1
9	fanconi anemia, complementation group e	10.1
10	superficial mycosis	10.1
11	ige responsiveness, atopic	10.0
12	herpes simplex	10.0
13	eczema herpeticum	10.0
14	dermatitis, atopic	10.0
15	dermatitis, atopic, 2	10.0
16	exanthem	10.0
17	tinea pedis	10.0
18	scalp dermatosis	10.0
19	tinea capitis	10.0
20	dermatophytosis	10.0
21	asthma	10.0
22	pityriasis versicolor	10.0
23	blepharitis	10.0
24	alopecia, androgenetic, 1	9.9
25	papillomatosis, confluent and reticulated	9.9
26	psoriasis 1	9.9
27	trichohepatoenteric syndrome 1	9.9
28	suppressor of tumorigenicity 11	9.9
29	psoriasis 2	9.9
30	psoriasis 7	9.9
31	psoriasis 11	9.9
32	psoriasis 13	9.9
33	androgenic alopecia	9.9
34	allergic disease	9.9
35	fungal infectious disease	9.9
36	telogen effluvium	9.9
37	contact dermatitis	9.9
38	breast adenocarcinoma	9.9
39	folliculitis	9.9
40	psoriasis	9.9
41	alopecia areata	9.9
42	demodicidosis	9.9
43	primary agammaglobulinemia	9.9
44	chronic bilirubin encephalopathy	9.9
45	ichthyosis, x-linked	9.7	PNPLA1 FLG
46	ichthyosis vulgaris	9.6	PNPLA1 FLG
47	ichthyosis, congenital, autosomal recessive 4b	9.6	PNPLA1 FLG CST6
48	ichthyosis	9.5	PNPLA1 FLG CST6
49	autosomal recessive congenital ichthyosis	9.5	PNPLA1 FLG CST6
50	epidermolytic hyperkeratosis	9.5	PNPLA1 FLG

Comorbidity relations with Seborrheic Infantile Dermatitis via Phenotypic Disease Network (PDN):

Acute Cystitis

Graphical network of the top 20 diseases related to Seborrheic Infantile Dermatitis:

Sources

Symptoms & Phenotypes for Seborrheic Infantile Dermatitis

Sources

Drugs & Therapeutics for Seborrheic Infantile Dermatitis

Drugs for Seborrheic Infantile Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 68)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Ciclopirox

Approved, Investigational

Phase 4

29342-05-0

2749

Ketoconazole

Approved, Investigational

Phase 4

65277-42-1, 142128-57-2

47576 3823 638701

Tacrolimus

Approved, Investigational

Phase 4

104987-11-3

6473866 445643

Petrolatum

Approved, Investigational

Phase 4

8009-03-8

Isotretinoin

Approved, Investigational, Nutraceutical

Phase 4

302-79-4, 4759-48-2

5538 444795 5282379

Calcitriol

Approved, Nutraceutical

Phase 4

32222-06-3

5280453

Emollients

Phase 4

Dermatologic Agents

Phase 4

Hormones

Phase 4

Hormone Antagonists

Phase 4

Cytochrome P-450 Enzyme Inhibitors

Phase 4

Cytochrome P-450 CYP3A Inhibitors

Phase 4

Calcineurin Inhibitors

Phase 4

Immunosuppressive Agents

Phase 4

Vasoconstrictor Agents

Phase 4

Calcium, Dietary

Phase 4

Calcium

Nutraceutical

Phase 4

7440-70-2

271

Pimecrolimus

Approved, Investigational

Phase 2, Phase 3

137071-32-0

17753757 6509979

Clobetasol

Approved, Experimental, Investigational

Phase 3

25122-46-7, 25122-41-2

2791 5311051 32798

Anti-Inflammatory Agents

Phase 2, Phase 3

Antirheumatic Agents

Phase 2, Phase 3

Anti-Inflammatory Agents, Non-Steroidal

Phase 2, Phase 3

Analgesics, Non-Narcotic

Phase 2, Phase 3

Analgesics

Phase 2, Phase 3

Sunscreening Agents

Phase 2, Phase 3

glucocorticoids

Phase 3

Azelaic acid

Approved

Phase 2

123-99-9

2266

Ichthammol

Approved

Phase 2

8029-68-3

Acetylcholine

Approved, Investigational

Phase 1

51-84-3

187

Neurotransmitter Agents

Phase 1

Botulinum Toxins

Phase 1

Cholinergic Agents

Phase 1

Hydrocortisone succinate

Approved

2203-97-6

3643

Hydrocortisone acetate

Approved, Vet_approved

50-03-3

Hydrocortisone

Approved, Vet_approved

50-23-7

3640 5754

Aminolevulinic acid

Approved

Early Phase 1

106-60-5

137

Allantoin

Approved

97-59-6

204

Triclosan

Approved, Investigational

3380-34-5

5564

Coal tar

Approved

8007-45-2

Miconazole

Approved, Investigational, Vet_approved

22916-47-8

4189

Clotrimazole

Approved, Vet_approved

23593-75-1

2812

Selenium

Approved, Investigational, Vet_approved

7783-07-5, 7782-49-2

533

Salicylic acid

Approved, Investigational, Vet_approved

69-72-7

338

Cholecalciferol

Approved, Nutraceutical, Vet_approved

67-97-0, 1406-16-2

5280795 10883523

Hydrocortisone 17-butyrate 21-propionate

Photosensitizing Agents

Early Phase 1

Gelatin Sponge, Absorbable

Antimetabolites

Hypolipidemic Agents

Anti-Infective Agents, Local

Interventional clinical trials:

(show all 36)

#	Name	Status	NCT ID	Phase	Drugs
1	Clinical, Laboratorial and Quality of Life Trial to Evaluate the Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea.	Unknown status	NCT01139749	Phase 4	oral isotretinoin;salicylic acid and ciclopirox olamine
2	A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)	Completed	NCT01214434	Phase 4
3	A PHASE 4, OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% IN THE TREATMENT OF SEBORRHEIC DERMATITIS	Completed	NCT00703846	Phase 4	Ketoconazole
4	Phase 4 Study of Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis	Completed	NCT01591070	Phase 4	Tacrolimus
5	A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis	Completed	NCT03567980	Phase 4	Crisaborole
6	A Double Blind Randomized Trial, Placebo-controled of 0.0003% Calcitriol Ointment Versus 0.1% Tacrolimus Ointment in the Treatment of Pityriasis Alba	Completed	NCT01388517	Phase 4	Tacrolimus;Calcitriol;Petrolatum
7	Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba: A Randomized Placebo-controlled Trial	Unknown status	NCT03834935	Phase 2, Phase 3	Elidel (pimecrolimus 1%);Cold Cream
8	Efficacy and Safety of Clobetasol Propionate Shampoo 0.05% Used in Association With an Antifungal Shampoo in the Treatment of Moderate to Severe Scalp Seborrheic Dermatitis	Completed	NCT00862654	Phase 3	clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week);ketoconazole shampoo (2/week)
9	Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face	Completed	NCT02004860	Phase 3	Protopic (R);Mycoster (R)
10	A Phase 3, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis	Completed	NCT04973228	Phase 3	ARQ-154 - Active;ARQ-154 Vehicle
11	Efficacy and Safety of ASF 1057 Cream 0.5% in the Treatment of Seborrhoeic Dermatitis: A Phase III Randomised, Double-Blind, Vehicle and Placebo Controlled, Parallel Groups, Multi-Centre Trial.	Completed	NCT00565279	Phase 3	ASF1057
12	A Phase 2, Randomized, Vehicle and Ketoconazole-Controlled, Evaluator-Blinded, Study to Explore the Efficacy, Pharmacodynamics and Safety of Omiganan 1.75% Topical Gel BID in Patients With Mild to Moderate Facial Seborrheic Dermatitis	Unknown status	NCT03688971	Phase 2	Omiganan;Ketoconazole;Placebo
13	A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face	Completed	NCT00408330	Phase 2	Azelaic Acid 15% Gel;Inactive 15% gel base
14	A Phase 2b, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Subjects With Seborrheic Dermatitis	Completed	NCT04091646	Phase 2	ARQ-154 foam 0.3%;ARQ-154 vehicle foam
15	A Randomized, Double-blind, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Seborrheic Dermatitis of the Face	Completed	NCT02749383	Phase 2	PAC-14028 cream 0.3%;PAC-14028 cream 1.0%;PAC-14028 cream vehicle
16	A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects With Seborrheic Dermatitis	Completed	NCT01703793	Phase 2	Test Product 49778;Test Product 10156;Vehicle (placebo)
17	A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis	Completed	NCT00403559	Phase 2	Elidel;Ketoconazole Cream
18	A Phase 2, Multicenter, Open-Label Study of the Long-Term Safety of ARQ-154 Foam 0.3% in Subjects With Seborrheic Dermatitis	Completed	NCT04445987	Phase 2	ARQ-154
19	The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage in Individuals With Multiple Skin Conditions A Double-Blind, Placebo Controlled Comparative Trial	Completed	NCT00991198	Phase 2	Topical oxygen;placebo
20	The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis	Completed	NCT02448082	Phase 2
21	Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients	Unknown status	NCT00767546	Phase 1	Botulinum toxin
22	Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation	Unknown status	NCT01315951
23	Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face.	Unknown status	NCT01024374
24	Using the SpiderMass(TM) for in Vivo and Real Time Mass Spectrometry Analysis of Subject's Epidermis Suffering From Chronic Inflammatory Dermatosis Compared to Control Groups	Unknown status	NCT04472546
25	An Open-Label Study of the HairMax LaserComb(r) in the Treatment of Seborrheic Dermatitis of the Scalp.	Completed	NCT00830908
26	Comparison of Scalp Microbiota of the Patients With Psoriasis Vulgaris and Seborrheic Dermatitis	Completed	NCT03807453
27	Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis	Completed	NCT02656368
28	Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis	Completed	NCT03114111	Early Phase 1	aminolevulinic acid (ALA);Placebo
29	Neurobiology of the Scalp in Seborrheic Dermatitis	Completed	NCT02349854
30	Multicentric, Randomized, Double Blind Study Under Dermatological Control for Evaluation of the Antidandruff Maintenance Effect of One Shampoo (Reference 1144628 D) Versus Its Vehicle (Reference 1144781) During 8 Weeks After a Ketoconazole-based Antifungal Treatment During 4 Weeks in Adult Subjects (Male and Female) With Light to Moderate Seborrheic Dermatitis	Completed	NCT04057950
31	Seborrheic Dermatitis of the Scalp in Populations Practicing Less Frequent Hair Washing: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo	Completed	NCT01203189		ketoconazole 2% foam;ketoconazole 2% shampoo
32	Retrospective Study to Evaluate the Safety of Sebryl® and / or Sebryl Plus® in the Treatment of Seborrheic Dermatitis and Psoriasis of the Scalp in Routine Medical Practice.	Completed	NCT05105139
33	Cleansing Device for the Treatment of Scalp and Hair Conditions	Recruiting	NCT05319444
34	Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba	Active, not recruiting	NCT03443765
35	Evaluation of the Efficacy of an Anti Dandruff Shampoo Against Placebo on Dandruff and Scalp Microflora Composition After 4 Weeks of Treatment and 4 Weeks of Relapse	Not yet recruiting	NCT05506592
36	Evaluation of the Antidandruff Effect of a Shampoo on Subjects With Dandruff and Slight Itching. Single-blind, Monocentric Study Realized Under Dermatological Control	Not yet recruiting	NCT05503706

Search NIH Clinical Center for Seborrheic Infantile Dermatitis

Inferred drug relations via UMLS ⁷¹ / NDF-RT ⁵⁰ :

Betamethasone

Betamethasone acetate

Betamethasone benzoate

betamethasone dipropionate

betamethasone sodium phosphate

Betamethasone valerate

BETAMETHASONE VALERATE PWDR

chloroxine

Coal Tar

Coal tar extract

Coal tar pitch volatiles

COAL TAR,COLLOIDAL

COAL TAR,REFINED

Colloid sulfur

Ketoconazole

Salicylic Acid

SALICYLIC ACID PWDR

selenium sulfide

Sulfacetamide

Sulfacetamide Sodium

Sulfur

SULFUR PWDR

SULFUR,COLLOIDAL

zinc pyrithione

Cochrane evidence based reviews: dandruff

Sources

Genetic Tests for Seborrheic Infantile Dermatitis

Sources

Anatomical Context for Seborrheic Infantile Dermatitis

Organs/tissues related to Seborrheic Infantile Dermatitis:

MalaCards : Skin, Liver

Sources

Publications for Seborrheic Infantile Dermatitis

Articles related to Seborrheic Infantile Dermatitis:

(show top 50) (show all 135)

#	Title	Authors	PMID	Year
1	From the Cochrane Library: Interventions for infantile seborrheic dermatitis (including cradle cap). ⁶²	Hassan S...Dellavalle RP	34571061	2022
2	An Overview of the Diagnosis and Management of Seborrheic Dermatitis. ⁶²	Dall'Oglio F...Micali G	35967915	2022
3	Cholinergic crisis caused by ingesting topical carpronium chloride solution: A case report. ⁶²	Endo T...Moriya T	34030906	2021
4	Not 'just cradle cap'. ⁶²		34902890	2021
5	Not 'just cradle cap'. ⁶²	Vijayanand S...Frazer FL	34902887	2021
6	Response to "Pityriasis capitis: Causes, pathophysiology, current modalities, and future approach". ⁶²	Schwartz JR	33314553	2021
7	An Infant With Seborrhoeic Dermatitis and Eczema Herpeticum Complicated by a Generalized Infection. ⁶²	Karpierz K...Kuchar EP	34522478	2021
8	Treatment of cradle cap in infants with a new cosmetic non-steroidal gel cream: Clinical, laboratory, and instrumental evaluation. ⁶²	Micali G...Lacarrubba F	33934474	2021
9	Pityriasis capitis: Causes, pathophysiology, current modalities, and future approach. ⁶²	Sheth U...Dande P	32416039	2021
10	Cutaneous disorders of adolescence among Nigerian secondary school students. ⁶²	Oyedepo JT...Adedoyin OT	32774612	2020
11	Seborrhea herpeticum: cutaneous herpes simplex virus infection within infantile seborrheic dermatitis. ⁶²	Steadman L...Haggstrom A	31886781	2019
12	Interventions for infantile seborrhoeic dermatitis (including cradle cap). ⁶²	Victoire A...van Driel ML	30828791	2019
13	Recurrent Vulvar Ulcers and "Cradle Cap" in a 2-Year-Old. ⁶²	Teran VA...Zlotoff BJ	30322698	2019
14	Seborrheic Dermatitis in Skin of Color: Clinical Considerations ⁶²	Elgash M...Taylor SC	30681789	2019
15	A systematic literature review of the human skin microbiome as biomarker for dermatological drug development. ⁶²	Niemeyer-van der Kolk T...Rissmann R	29877593	2018
16	The efficacy of a pseudo-ceramide and eucalyptus extract containing lotion on dry scalp skin. ⁶²	Takagi Y...Kawashima M	29670385	2018
17	Infantile seborrheic dermatitis: a pediatric Siddha medicine treatise. ⁶²	Thambyayah M...Amuthan A	25889138	2015
18	Topical, Non-Medicated LOYON(®) in Facilitating the Removal of Scaling in Infants and Children with Cradle Cap: a Proof-of-Concept Pilot Study. ⁶²	Hengge UR	25119137	2014
19	A clinical and statistical survey of cutaneous changes in the first 120 hours of life. ⁶²	Sadana DJ...Jethani S	25484382	2014
20	Re: 'Cradle cap' in puppies. ⁶²	Carlotti DN	24852825	2014
21	Cradle cap. ⁶²	Das A...Das NK	24986302	2014
22	Retrospective analysis of the relationship between infantile seborrheic dermatitis and atopic dermatitis. ⁶²	Alexopoulos A...Chrousos G	24224924	2014
23	Improving the management of seborrhoeic dermatitis. ⁶²	Ooi ET...Tidman MJ	24689165	2014
24	Utilization of matrix-assisted laser desorption and ionization time-of-flight mass spectrometry for identification of infantile seborrheic dermatitis-causing Malassezia and incidence of culture-based cutaneous Malassezia microbiota of 1-month-old infants. ⁶²	Yamamoto M...Makimura K	24387229	2014
25	'Cradle cap' in puppies? ⁶²	Scott DW	24289188	2014
26	Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. ⁶²	Dessinioti C...Katsambas A	23806151	2013
27	A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis). ⁶²	David E...Kircik LH	23652893	2013
28	Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences. ⁶²	Herrera-Arellano A...Martinez-Rivera MA	24146467	2013
29	The LINA cohort: indoor chemical exposure, circulating eosinophil/basophil (Eo/B) progenitors and early life skin manifestations. ⁶²	Weisse K...Denburg J	22925320	2012
30	Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis. ⁶²	Wananukul S...Charutragulchai W	21790793	2012
31	Mucocutaneous disorders in children with down syndrome: case-controlled study. ⁶²	Bilgili SG...Ozkol HU	22303799	2011
32	A new postulate on two stages of dandruff: a clinical perspective. ⁶²	Manuel F...Ranganathan S	21769228	2011
33	Olive oil for cradle cap? ⁶²	Williams C	21121479	2010
34	Erythroderma in children. ⁶²	Sarkar R...Garg VK	20657113	2010
35	The spectrum of skin disease among Indian children. ⁶²	Sardana K...Garg VK	19250398	2009
36	Central serous chorioretinopathy associated with unusual routes of steroid administration. ⁶²	Mirza RG...Gill M	25390854	2009
37	Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance. ⁶²	Herrera-Arellano A...Tortoriello J	18058612	2007
38	Management of infantile seborrheic dermatitis. ⁶²	Arora V...Arora S	17390592	2007
39	Clinical inquiries. What's the best treatment for cradle cap? ⁶²	Sheffield RC...King VJ	17343816	2007
40	On top of cradle cap. ⁶²	Smoker AL	17824212	2007
41	Infantile seborrheic dermatitis. ⁶²	Elish D...Silverberg NB	16776285	2006
42	The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. ⁶²	Ro BI...Dawson TL	16382662	2005
43	Malassezia furfur in infantile seborrheic dermatitis. ⁶²	Wananukul S...Poovorawan Y	16252839	2005
44	Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. ⁶²	Wannanukul S...Chiabunkana J	16083165	2004
45	Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole. ⁶²	Herrera-Arellano A...Tortoriello J	15241887	2004
46	Should we treat infantile seborrhoeic dermatitis with topical antifungals or topical steroids? ⁶²	Cohen S	14977719	2004
47	Seborrheic dermatitis. ⁶²	Gupta AK...Bluhm R	14678527	2004
48	The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). ⁶²	Foley P...Marks R	12622623	2003
49	Cutaneous lesions in new born. ⁶²	Sachdeva M...Dewan SP	17656992	2002
50	[Seborrheic dermatitis of infancy]. ⁶²	Prigent F	12416520	2002

Sources

Genes for Seborrheic Infantile Dermatitis

Genes related to Seborrheic Infantile Dermatitis (0 elite genes):

(show all 11)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	DOP1B	DOP1 Leucine Zipper Like Protein B	Protein Coding	5.79	DISEASES inferred ¹⁴
2	RPL39L	Ribosomal Protein L39 Like	Protein Coding	5.78	DISEASES inferred ¹⁴
3	TECR	Trans-2,3-Enoyl-CoA Reductase	Protein Coding	5.19	DISEASES inferred ¹⁴
4	CST6	Cystatin E/M	Protein Coding	5.14	DISEASES inferred ¹⁴
5	IL17RE	Interleukin 17 Receptor E	Protein Coding	4.81	DISEASES inferred ¹⁴
6	IL17RD	Interleukin 17 Receptor D	Protein Coding	4.77	DISEASES inferred ¹⁴
7	PNPLA1	Patatin Like Phospholipase Domain Containing 1	Protein Coding	4.74	DISEASES inferred ¹⁴
8	TPSD1	Tryptase Delta 1	Protein Coding	4.62	DISEASES inferred ¹⁴
9	MPZL3	Myelin Protein Zero Like 3	Protein Coding	4.54	DISEASES inferred ¹⁴
10	FLG	Filaggrin	Protein Coding	4.49	DISEASES inferred ¹⁴
11	ZNF750	Zinc Finger Protein 750	Protein Coding	4.37	DISEASES inferred ¹⁴